EP3608312 - SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 24.05.2024 Database last updated on 28.06.2024 | |
Former | Grant of patent is intended Status updated on 04.02.2024 | ||
Former | Examination is in progress Status updated on 10.01.2024 | ||
Former | Grant of patent is intended Status updated on 01.01.2024 | ||
Former | Examination is in progress Status updated on 29.10.2021 | ||
Former | Request for examination was made Status updated on 10.01.2020 | ||
Former | The international publication has been made Status updated on 13.10.2018 | Most recent event Tooltip | 24.05.2024 | (Expected) grant | published on 26.06.2024 [2024/26] | Applicant(s) | For all designated states Xiamen Vivohealths Technology Co., Ltd. Room 602, Building B13 Xiamen Bio-medicine Industrial Park 2074 West Wengjiao Road Haicang District Xiamen, Fujian 361027 / CN | [2020/07] | Inventor(s) | 01 /
DENG, Xianming 4221-120 Xiang'an South Road Xiang'an District Xiamen Fujian 361102 / CN | 02 /
LIN, Shengcai 4221-120 Xiang'an South Road Xiang'an District Xiamen Fujian 361102 / CN | 03 /
ZHANG, Chensong 4221-120 Xiang'an South Road Xiang'an District Xiamen Fujian 361102 / CN | [2020/07] | Representative(s) | Colombo, Stefano Paolo, et al Marchi & Partners S.r.l. Via Vittor Pisani, 13 20124 Milano / IT | [2020/07] | Application number, filing date | 18781729.1 | 04.04.2018 | [2020/07] | WO2018CN81898 | Priority number, date | CN201710223125 | 07.04.2017 Original published format: CN201710223125 | [2020/07] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018184561 | Date: | 11.10.2018 | Language: | ZH | [2018/41] | Type: | A1 Application with search report | No.: | EP3608312 | Date: | 12.02.2020 | Language: | EN | [2020/07] | Type: | B1 Patent specification | No.: | EP3608312 | Date: | 26.06.2024 | Language: | EN | [2024/26] | Search report(s) | International search report - published on: | CN | 11.10.2018 | (Supplementary) European search report - dispatched on: | EP | 29.09.2020 | Classification | IPC: | C07D235/08, C07D233/02, A61K31/4184, A61K31/4174, A61P3/06, A61P25/28, A61P35/00, A61P1/16 | [2020/07] | CPC: |
A61P1/16 (EP);
C07D233/60 (EP,CN,US);
A61P25/16 (EP);
A61P25/28 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P3/10 (EP);
A61P35/00 (EP);
A61P39/06 (EP);
C07D233/56 (CN);
C07D233/58 (EP,CN);
C07D233/61 (CN,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/07] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | SUBSTITUIERTE IMIDAZOLSALZVERBINDUNGEN, HERSTELLUNGSVERFAHREN DAFÜR, PHARMAZEUTISCHE ZUSAMMENSETZUNG DAVON UND ANWENDUNGEN DAVON | [2020/07] | English: | SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATIONS THEREOF | [2020/07] | French: | COMPOSÉS DE SEL D'IMIDAZOLE SUBSTITUÉS, LEUR PROCÉDÉ DE PRÉPARATION, COMPOSITION PHARMACEUTIQUE ET APPLICATIONS ASSOCIÉES | [2020/07] | Entry into regional phase | 04.11.2019 | Translation filed | 04.11.2019 | National basic fee paid | 04.11.2019 | Search fee paid | 04.11.2019 | Designation fee(s) paid | 04.11.2019 | Examination fee paid | Examination procedure | 04.11.2019 | Examination requested [2020/07] | 26.04.2021 | Amendment by applicant (claims and/or description) | 03.11.2021 | Despatch of a communication from the examining division (Time limit: M06) | 02.05.2022 | Reply to a communication from the examining division | 09.08.2022 | Despatch of a communication from the examining division (Time limit: M04) | 12.12.2022 | Reply to a communication from the examining division | 28.03.2023 | Despatch of a communication from the examining division (Time limit: M04) | 21.07.2023 | Reply to a communication from the examining division | 02.01.2024 | Communication of intention to grant the patent | 09.01.2024 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 05.02.2024 | Communication of intention to grant the patent | 20.05.2024 | Fee for grant paid | 20.05.2024 | Fee for publishing/printing paid | 20.05.2024 | Receipt of the translation of the claim(s) | Fees paid | Renewal fee | 04.11.2019 | Renewal fee patent year 03 | 30.04.2021 | Renewal fee patent year 04 | 27.04.2022 | Renewal fee patent year 05 | 29.03.2023 | Renewal fee patent year 06 | 29.04.2024 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X]BE696982 ; | [A]WO2008006432 (MERCK PATENT GMBH [DE], et al); | [X]WO2014199352 (INVICTUS ONCOLOGY PVT LTD [IN]); | International search | [A]WO2009123569 (AGENCY SCIENCE TECH & RES [SG], et al); | [A]WO2009133923 (ISHIHARA SANGYO KAISHA [JP], et al); | [A]CN101983057 (AGENCY SCIENCE TECH & RES); | [A]CN103547154 (UNIV AKRON) | Examination | DE2706839 | JP2009215200 | CN101698660 | US8592585 | WO2018106922 |